share_log

Cambricon Technologies Corporation Limited (SHSE:688256) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Cambricon Technologies Corporation Limited (SHSE:688256) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

劍橋科技有限公司(SHSE: 688256)上週公佈了收益,分析師已經上調了預期
Simply Wall St ·  05/01 19:50

Cambricon Technologies Corporation Limited (SHSE:688256) missed earnings with its latest quarterly results, disappointing overly-optimistic forecasters. Earnings missed the mark, with revenues of CN¥26m falling badly (74%) short of expectations. Losses were mildly higher, with a CN¥0.54 per-share loss being 3.8% above what the analysts modelled. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

劍橋科技有限公司(上海證券交易所股票代碼:688256)的最新季度業績未達到收益,令過於樂觀的預測者失望。收益未達到目標,2600萬元人民幣的收入嚴重低於預期(74%)。虧損略高,每股虧損0.54元人民幣,比分析師的模型高出3.8%。分析師通常會在每份收益報告中更新他們的預測,我們可以從他們的估計中判斷他們對公司的看法是否發生了變化,或者是否有任何新的問題需要注意。因此,我們收集了最新的業績後法定共識估計,以了解明年可能會發生什麼。

earnings-and-revenue-growth
SHSE:688256 Earnings and Revenue Growth May 1st 2024
SHSE: 688256 收益和收入增長 2024 年 5 月 1 日

Taking into account the latest results, the most recent consensus for Cambricon Technologies from five analysts is for revenues of CN¥1.70b in 2024. If met, it would imply a major 158% increase on its revenue over the past 12 months. The loss per share is expected to greatly reduce in the near future, narrowing 40% to CN¥1.19. Before this latest report, the consensus had been expecting revenues of CN¥1.42b and CN¥1.37 per share in losses. So there's been quite a change-up of views after the recent consensus updates, with the analysts making a sizeable increase to their revenue forecasts while also reducing the estimated loss as the business grows towards breakeven.

考慮到最新業績,五位分析師對Cambricon Technologies的最新共識是,2024年的收入爲17.0億元人民幣。如果得到滿足,這意味着其收入在過去12個月中將大幅增長158%。預計每股虧損將在不久的將來大幅減少,縮小40%至1.19元人民幣。在這份最新報告之前,共識一直預計收入爲14.2億元人民幣,每股虧損1.37元人民幣。因此,在最近的共識更新之後,觀點發生了很大變化,分析師大幅提高了收入預期,同時隨着業務向盈虧平衡的方向發展,也減少了估計的虧損。

It will come as no surprise to learn thatthe analysts have increased their price target for Cambricon Technologies 11% to CN¥127on the back of these upgrades. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Cambricon Technologies, with the most bullish analyst valuing it at CN¥210 and the most bearish at CN¥84.40 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

在這些升級的支持下,分析師將劍橋科技的目標股價上調了11%,至127元人民幣也就不足爲奇了。研究分析師的估計範圍,評估異常值與平均值的差異程度也可能很有啓發性。對Cambricon Technologies的看法有所不同,最看漲的分析師將其估值爲210元人民幣,最看跌的爲每股84.40元人民幣。注意到分析師目標股價的巨大差距了嗎?對我們來說,這意味着基礎業務存在相當廣泛的可能情景。

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. The analysts are definitely expecting Cambricon Technologies' growth to accelerate, with the forecast 254% annualised growth to the end of 2024 ranking favourably alongside historical growth of 7.3% per annum over the past three years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 23% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Cambricon Technologies is expected to grow much faster than its industry.

我們可以從大局的角度看待這些估計值的另一種方式,例如預測如何與過去的表現相提並論,以及預測相對於業內其他公司是否或多或少看漲。分析師們肯定預計,劍橋科技的增長將加速,預計到2024年底的年化增長率爲254%,而過去三年的歷史年增長率爲7.3%。相比之下,我們的數據表明,預計類似行業的其他公司(有分析師報道)的收入將以每年23%的速度增長。考慮到收入增長的預測,很明顯,劍橋科技的增長速度預計將比其行業快得多。

The Bottom Line

底線

The most obvious conclusion is that the analysts made no changes to their forecasts for a loss next year. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

最明顯的結論是,分析師對明年虧損的預測沒有改變。令人高興的是,他們還上調了收入預期,並預測其增長速度將超過整個行業。目標股價也大幅提高,分析師顯然認爲該業務的內在價值正在提高。

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Cambricon Technologies going out to 2026, and you can see them free on our platform here..

考慮到這一點,我們仍然認爲該業務的長期發展軌跡對於投資者來說更爲重要。在Simply Wall St,我們有分析師對Cambricon Technologies到2026年的全方位估計,你可以在我們的平台上免費看到這些估計。

However, before you get too enthused, we've discovered 1 warning sign for Cambricon Technologies that you should be aware of.

但是,在你變得太熱情之前,我們已經發現了Cambricon Technologies的1個警告信號,你應該注意這一點。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論